Injectable GLP-1-based therapies, including semaglutide and tirzepatide, have demonstrated substantial benefits for weight loss and cardiometabolic risk reduction ( 1 3 ), but real-world uptake has been shaped by factors such as route of administration, access, tolerability, and insurance coverage ( 4 7 )
The guide to how to microdose tirzepatide covers the practical aspects of drawing and administering these very small volumes accurately
2018 Jun;15(6):5077-5083
From their beginnings as a treatment for type 2 diabetes, GLP-1 receptor agonists such as the semaglutide drugs Ozempic and Wegovy and the tirzepatide drugs Mounjaro and Zepbound have seen an explosion in use, most popularly for weight loss
Understanding this established side effect profile provides important context when patients report symptoms that fall outside typical patterns, such as skin-related concerns
You can watch by clicking this link here this link here Want More Like This